Rhabdomyolysis associated with concomitant use of simvastatin and clarithromycin

被引：21

作者：

Kahri, AJ ^{[1
]}

Valkonen, MM ^{[1
]}

Vuoristo, MKE ^{[1
]}

Pentikäinen, PJ ^{[1
]}

机构：

[1] Univ Helsinki, Cent Hosp, Dept Internal Med, HUS 00029, Finland

来源：

ANNALS OF PHARMACOTHERAPY | 2004年 / 38卷 / 04期

关键词：

D O I：

10.1345/aph.1D243

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：719 / 719

页数：1

共 5 条

[1] Erythromycin and verapamil considerably increase serum simvastatin and simvastatin acid concentrations [J].

Kantola, T ;

Kivistö, KT ;

Neuvonen, PJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 64 (02) :177-182

[2] Current perspectives on statins [J].

Maron, DJ ;

Fazio, S ;

Linton, MF .

CIRCULATION, 2000, 101 (02) :207-213

[3] A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS [J].

NARANJO, CA ;

BUSTO, U ;

SELLERS, EM ;

SANDOR, P ;

RUIZ, I ;

ROBERTS, EA ;

JANECEK, E ;

DOMECQ, C ;

GREENBLATT, DJ .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) :239-245

[4] Clinical importance of the cytochromes P450 [J].

Nebert, DW ;

Russell, DW .

LANCET, 2002, 360 (9340) :1155-1162

[5]

Stein EA, 2002, AM J CARDIOL, V89, p50C

← 1 →